Introduction
============

The main goal of a two stage hip revision in periprosthetic joint infection (PJI) is the elimination of all bacteria and biofilm. To eliminate the risk of residual bacterial reservoirs or biofilm a removal of all foreign material is preferred and the introduction of new hardware is avoided whenever possible [@B1], [@B2].

In cases of a well-fixed stem or extensive cementation an extended trochanteric osteotomy or an osseous window may be necessary during the explantation procedure also in septic cases [@B3]-[@B5]. In these cases, an osteosynthesis using wire- or band-cerclages becomes necessary to fixate the osteotomy and restore the stability of the proximal femur [@B4], [@B5]. However, this in turn means the introduction of new foreign material in a potentially septic environment.

Previous sonication studies were able to show that the bacterial biofilm in PJI encompasses the entire joint and all intraarticular components, independent of component type or material [@B6]-[@B8].

During septic two-stage total joint arthroplasty revision, this bacterial colonization also occurs to newly introduced foreign material, such as antibiotic-loaded polymethylmethacrylate (PMMA) spacers, after component explantation and surgical debridement [@B9]-[@B13]. Despite the continuous antimicrobial therapy the bacterial colonization of PMMA-spacers, detected at the time of component reimplantation, has been shown to result in increased rates of future septic failure [@B11]-[@B13].

It is currently unclear if this bacterial colonization also occurs with newly implanted femoral cerclages after performance of a femoral osteotomy, to explant a well-fixed stem, in cases of septic two-staged THA-revision. Furthermore, it is unclear if a bacterial colonization of cerclage hardware also results in increased rates of future septic failure.

Hence, it was the goal of this study to investigate if a bacterial colonization of cerclage hardware occurs during two-stage septic THA revision and if this poses a risk for future septic failure.

Patients and Methods
====================

Study design and patient population
-----------------------------------

Twenty-nine patients undergoing THA revision surgery between 2011 and 2016 were included in this retrospective cohort study. Approval from our institutional review board was obtained prior to commencement of this study. Inclusion criteria were removal of femoral cerclage hardware during septic two-stage THA revision. Exclusion criteria were a missing sonication of cerclage hardware, cerclage removal during the first-stage explantation procedure or cerclage removal for any other reason. Two patients were excluded because of a missing sonication of cerclage hardware and four patients were excluded due to incomplete microbiological sampling leaving 23 patients for evaluation. From these 23 patients four received a cerclage removal during a second round of irrigation and debridement (I&D) for PJI persistence and 19 patients received an explantation of the cerclage hardware during the second stage THA reimplantation.

The average patient age in our cohort was 74 years \[49 - 91 years\]. The average duration of the THAs *in situ* was 35 months and 14 of the 23 THAs had a failure within 24 months of implantation. The type of PJI was also assessed. There was one case of early PJI, 13 cases of delayed PJI and nine cases of late PJI [@B14]. The average duration of the Girdlestone interval was 3,4 months \[1,5-20 months\].

The following samples were acquired intraoperatively: multiple periprosthetic tissue samples (minimum of five samples), periprosthetic membrane for histological samples, synovial fluid, as well as sonicate fluid cultures (SFC) of the explanted prosthetic parts (1^st^ stage) and cerclages (2^nd^ stage). Sonication was performed for three minutes using a BactoSonic 14.2 (Bandelin, Berlin, Germany) sonication unit with subsequent microbiological culture of the sonicate fluid in blood culture bottles and conventional agar plate cultures [@B15], [@B16]. All microbiological samples, including sonicate fluid cultures, were cultured for 14 days to allow for the detection of fastidious species [@B17].

The presence of PJI was defined according to the following criteria: presence of intraarticular pus or a sinus tract, positive isolation of the same bacterial species in a minimum of two microbiological samples or a histological membrane indicative of infection [@B18], [@B19].

All of the 23 two-staged septic THA revisions included in this study were of cementless fixation and were treated at our department according to the following standardized protocol. After establishment of the diagnosis of PJI, the first stage explantation procedure consists of a complete explantation of all arthroplasty components and foreign materials to create a true Girdlestone resection arthroplasty. In all cases an extended trochanteric osteotomy or other femoral osteotomy was necessary to remove a well-fixed stem and cerclages were used to restore the stability of the proximal femur (Figure [1](#F1){ref-type="fig"}). During the explantation procedure the following samples were acquired: synovial fluid, multiple periprosthetic tissue samples, a sonication of the explanted arthroplasty components as well as a histological sample of the periprosthetic membrane. The grading of the periprosthetic membrane was performed according to the consensus classification of Morawietz et al [@B20]. After the explantation procedure i.v. antibiotic therapy was initiated according to current international therapy guidelines [@B2], [@B19]. In general, i.v. antibiotics were administered for the first two weeks, adjusted if necessary in accordance with the antibiotic sensibility, and continued orally for a minimum of four weeks [@B2]. The specific oral antibiotic treatment is continued without interruption until the second stage reimplantation procedure[@B2]. No biofilm-active antibiotics were administered between the first and second stage. If the paraclinical serum infection parameters (CRP) were either continuously falling or within normal values after completion of a minimum of six weeks of antimicrobial therapy, then the THA-reimplantation was performed. If the paraclinical infection parameters were continuously elevated after completion of the antimicrobial therapy, or if there were clinical sign of infection persistence such as erythema or calor, this was interpreted as a persistence of PJI and a second round of I&D including an exchange of the existing ceclages was performed and an extended course of antimicrobial therapy for an additional six weeks was initiated.

From the 23 patients included in this study, 19 patients received an explantation of the cerclage hardware during the second-stage THA-reimplantation and four patients received an explantation of the cerclage hardware during a second I&D procedure for infection persistence.

The positive bacterial isolations from the individual microbiological methods were recorded at the time of THA-explantation and THA-reimplantation (Table [1](#T1){ref-type="table"}). The further clinical outcome after THA-reimplantation was also recorded for all patients and classified as *in situ*, I&D with or without bearing exchange and THA-revision or THA-explantation.

All statistical calculations were performed using SPSS 15 (Statistical Package for Social Sciences, Inc., Chicago, IL, USA). The statistical significances for risk of THA-revision between the patients with positive cerclage-SFC and patients with negative cerclage-SFC was calculated using Χ^2^ test and the cut off for statistical significance was defined as p = 0,05.

Results
=======

In our entire patient cohort seven of 23 (30%) cerclage-SFC produced a positive bacterial isolation. Six positive bacterial isolations were from cerclage-SFC during THA-reimplantation and one positive isolation was from a cerclage-SFC during a second I&D procedure. Table [1](#T1){ref-type="table"} displays the results of the intraoperative microbiological samples for the 19 patients undergoing THA re-implantation. Six of these 19 patients (32%) produced a positive bacterial isolation by cerclage-SFC. In accordance with our criteria for THA re-implantation, none of these patients presented any preoperative clinical or laboratory signs of infection persistence (erythema, calor, persistent pain or elevated serum CRP) prior to second-stage surgery.

To investigate the clinical relevance of a positive cerclage-SFC, the further clinical course and survival of the 19 cases, with a sonication of cerclage hardware from the second-stage THA reimplantation, were recorded. Six of theses 19 patients, showed a positive bacterial growth in the cerclage-SFC. Only one of these six patients fulfilled the PJI criteria, due to a positive histology at THA reimplantation. From these six patients four patients underwent revision surgery (66%). Two patients received an additional I&D, one patient received a THA explantation and one patient a cup exchange. Thirteen of 19 patients showed no growth in the cerclage-SFC from the second-stage THA reimplantation. From these 13 patients only a single patient fulfilled the PJI criteria and four patients underwent revision surgery (31%). Three received an I&D and one patient received a stem exchange. The group with positive cerclage-SFC had a higher revision rate than the group with negative cerclage-SFC, 31% vs. 66%, although this difference was not significant (p= 0,14).

Discussion
==========

Our data shows that femoral cerclages, implanted during the explantation procedure, represent a risk factor for bacterial colonization and persistence during septic two stage THA exchange. This means colonization also occurs on femoral cerclages introduced after femoral osteotomy during THA explantation for PJI, despite the surgical debridement and postoperative antimicrobial therapy. While previous studies have been able to demonstrate that the bacterial colonization in PJI is present on PMMA-spacers during two-stage septic revision surgery, this study is the first to show, that this colonization is also present on cerclage hardware [@B9]-[@B13].

Currently, there are no recommendations in the literature regarding the management of *in situ* cerclage hardware in the setting of a two-staged septic THA exchange. If a femoral osteotomy becomes necessary to explant a well-fixed stem a re-fixation of the osteotomy through sutures, wire-, cable- or band-cerclages becomes necessary. In turn, this results in the dilemma of introducing new hardware into a septic, albeit a freshly debrided, situs.

One possible solution is the utilization of alternative fixation materials, such as sutures, for the refixation of the femoral osteotomy [@B21]. This method was first described with the intention of reducing the mechanical complications of wire or cable cerclages, such as disruption of the osteotomy\'s blood supply or avoiding metal on metal contact. However, it remains unclear if the utilization of sutures might reduce the bacterial colonization present on foreign body hardware during the first- and second-stage interval [@B21]. Previous sonication studies have shown that there is an even higher bacterial adherence to synthetic surfaces, such as PE and possibly sutures, in comparison to metal or ceramic surfaces [@B7].

The major limitation of this study is the small sample size, despite the long inclusion period. This is due to the fact that the combination of a femoral osteotomy and a two-stage THA exchange is a relatively rare event, even at a large tertiary care center. Due to the small sample size, the investigation of patient specific risk factors for bacterial colonization of cerclage hardware or infection persistence is not possible, due to a lack of statistical power. Additionally, a longer follow up period might reveal an even higher rate of septic failure for the cases with a positive SFC of cerclage hardware.

A second limitation of this study is indebted to the fact that no spacers were used and a true Girdlestone resection arthroplasty was performed. We do not employ PMMA-spacers due to the high rate of mechanical complications, such as spacer breakage or dislocation and the contraindicated use of spacers in the presence of severe acetabular osseous defects [@B22]-[@B24]. However, the majority of the published results in the current literature include PMMA-spacer making a direct comparison with our results difficult [@B9]-[@B13]. Although a theoretical argument could be made, that the presence of an antibiotic-eluting spacer could decrease the rate of bacterial colonization of the *in situ* cerclage hardware, there is no evidence to support this assumption. Sonication of retrieved of antibiotic-eluting spacers have shown that a bacterial colonization of the spacer surface occurs and that this colonization is highly predictive of future septic failure [@B9], [@B11]-[@B13], [@B25].

The interpretation of the bacterial species isolated from the cerclage hardware is also encumbered by the small sample size. The isolation of a bacterial species from the cerclage hardware differing from the bacterial species isolated during the first-stage explantation procedure is a common problem, reported in all sonication studies investigating PMMA-spacers [@B9]-[@B13], [@B25]. This phenomenon of isolating a differing bacterial species between the first- and second-stage surgery, allows several possible interpretations. Firstly, polymicrobial infections are reported in up to 30% of all cases of PJI and the detection rate of polymicrobial infections through sonication is superior to that of the conventional microbiological methods [@B26]. Secondly, it is possible that the species isolated from the cerclage hardware were selected through the continuous antimicrobial therapy given from the THA-explantation until THA-reimplantation [@B27]. The selection of small colony variants is known to develop under antimicrobial therapy, pose a risk factor for infection persistence and have been isolated in up to 34% of PJI-cases [@B27]-[@B31]. The other two possible explanations are that the additional species represent either an intraoperative contamination during THA reimplantation or a contamination of the microbiological sample, either during intraoperative acquisition, sample processing or the culture process.

The results of this study exemplify the importance of removing all foreign material, including cerclage hardware, in cases of PJI, since all foreign material poses a potential reservoir for residual bacteria [@B9], [@B11], [@B13], [@B25]. While this study is the first to report the risk of bacterial colonization associated with retained cerclage hardware in two stage THA exchange, this has already been shown for two stage septic exchanges with spacers in knees and hips [@B9], [@B11], [@B13]. Also, this study is the first to demonstrate the diagnostic benefits of a sonication of removed cerclage hardware.

In conclusion, while femoral cerclages are necessary to restore the stability of the proximal femur after prior osteotomy, they also pose the risk of bacterial colonization. Due to this bacterial colonization, cerclage hardware should be removed or exchanged during second- stage reimplantation and in cases of unsure infection control, the surgeon\'s threshold for performing a second debridement and removal of all cerclage hardware should be very low.
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###### 

Overview over the microbiological culture results of the first-stage explantation and second-stage reimplantation procedure for patients undergoing two-stage septic THA exchange.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Case Nr.   Explantation procedure\                    Synovial aspiration or peri-prosthetic tissue (second-stage)   Cerclage sonication (second-stage)
             (first-stage)                                                                                             
  ---------- ------------------------------------------ -------------------------------------------------------------- ------------------------------------
  1          Staph. epidermidis                         *without growth*                                               *without growth*

  2          Staph. sanguinis                           Staph. epidermidis                                             Staph haemolyticus

  4          Staph. aureus & Enterococcus faecalis      Staph. epidermidis                                             *without growth*

  6          Prop. acnes                                *without growth*                                               *without growth*

  7          Staph. epidermidis                         *without growth*                                               *without growth*

  9          Staph. epidermidis                         *without growth*                                               Micrococcus luteus

  10         Enterococcus faecalis                      *without growth*                                               Staph. hominis

  11         *without growth*                           *without growth*                                               *without growth*

  12         Finegoldia magna                           *without growth*                                               *without growth*

  13         Staph. aureus                              *without growth*                                               *without growth*

  14         Staph. epidermidis + Staph. haemolyticus   *without growth*                                               Prop. acnes

  15         Staph. epidermidis                         *without growth*                                               *without growth*

  17         Propionibacterium acnes                    *without growth*                                               *without growth*

  18         *without growth*                           *without growth*                                               Staph. cohnii

  19         *without growth*                           *without growth*                                               *without growth*

  20         Finegoldia magna                           *without growth*                                               *without growth*

  21         Escherichia coli                           Staph. epidermidis                                             *without growth*

  22         Staph. lugdunensis & Staph. epidermidis    *without growth*                                               Staph. epidermidis

  23         MRSA                                       *without growth*                                               *without growth*
  ---------------------------------------------------------------------------------------------------------------------------------------------------------
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